InvestorsHub Logo
Followers 129
Posts 3809
Boards Moderated 0
Alias Born 07/12/2003

Re: BonnieMac post# 169394

Thursday, 02/02/2023 9:29:42 AM

Thursday, February 02, 2023 9:29:42 AM

Post# of 198626
Nope that is the SEC job to stop illegal manipulation.

It is the CEO job is to create sustained value for shareholders.

Big Pharma don't care nothing about what is going on with ENZC stock.

Big Pharma only want ENZC technology.

What did Regeneron CEO say about their next Covid Antibody:

Regeneron, which early on in the pandemic developed a monoclonal antibody cocktail to address a treatment paradigm for COVID, is pivoting to what CEO Len Schleifer called “the jackpot antibody.”


Why did he call it the “the jackpot antibody.”

Binding site outside of immunodominant, highly variable RBD and NTD regions, lowering risk of losing activity against future variants

Targeted epitope highly conserved, with over 99.9% conservation since beginning of the pandemic

How does Regeneron process compares to Enzolytics process?

The Enzolytics’ proprietary methodology for creating hybridomas produces a specific monoclonal antibody secreted by human immune B cells—obtained from convalescent donor patients—followed by isolating a single cell that produces a monoclonal antibody that targets an identified conserved epitope on the virus.